Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02600624 · ClinicalTrials.gov registry record
Prenatal Alcohol Biomarker Study in Uruguay
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 1,412
- Enrollment target
NCT02600624: Completed study, sponsored by Northwestern University.
NCT02600624 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 1,412 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02600624 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 1,412 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the association between maternal alcohol use and newborn phosphatidylethanol (PEth) levels in their newborn.
Primary Outcome
Conduct a formative assessment of the prevalence and patterns of maternal alcohol consumption during pregnancy and the relationship of these reported patterns to maternal biomarker levels (EtG in hair and nails and PEth in blood) in a large sample (n=1800) of pregnant women in Montevideo, Uruguay.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,412 participants |
| Start Date | 2016-08-18 |
| Est. Completion | 2019-07 |
What the finished NCT02600624 record still lists
NCT02600624 is an observational study that tracks outcomes without assigning an intervention. Its 1,412 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT02600624 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02600624 about?
NCT02600624 is a clinical study titled "Prenatal Alcohol Biomarker Study in Uruguay". The purpose of this study is to examine the association between maternal alcohol use and newborn phosphatidylethanol (PEth) levels in their newborn.
What is the current status of trial NCT02600624?
This trial is currently completed. The enrollment target is 1,412 participants. The study started on 2016-08-18. Estimated completion is 2019-07.
Who is sponsoring clinical trial NCT02600624?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05890404 · 1,410 participants · NA
SGM Evidenced-Based Mental Healthcare Implementation
- NCT07042451 · 1,410 participants · NA
An Evaluation of the Pink Cloud Application in Post- Treatment Substance Use Disorder Support
- NCT07222566 · 1,410 participants · Phase 3
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- NCT05992935 · 1,405 participants · Phase 1
Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI